Regeneration specialist U+I is on track to report “record development and trading gains” in the 2018 full year, in line with its previously stated target of £65-70m.
This compares with £35m in 2017.
Chief executive, Matthew Weiner, said: “This has been an impressive year for U+I as we achieved record development and trading gains. This is just the beginning. We have the right team and strategy in place to continue to deliver sustainable year on year returns for our shareholders.
“I look forward to sharing positive news on the progress across our portfolio and our outlook for FY19 at the full year results.”
